Company news
Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A (SSE:603392) news
Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A news releases on 6ix. Latest, Apr 25, 2025: Announcement on Provision for Asset Impairment…
View Beijing Wantai Biological Pharmacy Enterprise Co. Ltd. Class A →
Press releases — page 2
Announcement on Provision for Asset Impairment in Q1 2025
April 24, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance and Cash Dividend Briefing
April 18, 2025
Announcement on Initiating Phase III Clinical Trial of 9-valent HPV Vaccine for Men and Completing the Enrollment of First Subject
April 14, 2025
Special Report on Annual Deposit and Actual Use of Raised Funds in 2024
April 11, 2025
Announcement on Inclusion of TB Specific T-cell Detection Kit EpiDot.TB (Enzyme-linked Immunosorbent Assay for In Vitro Release ) into the Purchase Order of United Nations Office for Project Services
April 9, 2025
Announcement on Opening a Special Account for Wealth Management and Signing a Tripartite Supervision Agreement for the Special Account of Raised Funds
March 14, 2025